These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3624101)

  • 1. Responsibilities of animal scientists and drug sponsors when conducting research with investigational new animal drugs.
    Knight WM
    J Anim Sci; 1987 Aug; 65(2):581-3. PubMed ID: 3624101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsibilities of university investigators when conducting trials on investigational new animal drugs.
    Parrott JC
    J Anim Sci; 1987 Aug; 65(2):577-80. PubMed ID: 3624100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The responsibilities of investigators, monitors, and sponsors of clinical studies supporting new animal drug applications. Center for Veterinary Medicine, FDA.
    Schoenemann HM; McCormack JF; Smedley KO
    J Anim Sci; 1995 Feb; 73(2):606-13; discussion 612-3. PubMed ID: 7601797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA's new drug evaluation process: a general overview.
    Walters PG
    J Public Health Dent; 1992; 52(6):333-7. PubMed ID: 1432918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigator-sponsored IND in clinical trials.
    Haakenson C; Fye CL; Sather MR; Toussaint DJ
    Control Clin Trials; 1987 Jun; 8(2):101-9. PubMed ID: 3608504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical investigation of new animal drugs by veterinary practitioners.
    Prater DA; Bertone JJ; Letonja T; Vaughn SD
    J Am Vet Med Assoc; 1996 Jan; 208(2):190-4. PubMed ID: 8567369
    [No Abstract]   [Full Text] [Related]  

  • 9. The conduct of clinical trials and good clinical practices: the sponsor's perspective. Food and Drug Administration.
    Robb EJ; Davis DD; Farrington DO
    J Anim Sci; 1995 Feb; 73(2):614-9; discussion 619-21. PubMed ID: 7601798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operation of a radiopharmacy for a clinical trial.
    Norenberg JP; Petry NA; Schwarz S
    Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures for emergency or treatment use of investigational drugs.
    Klecker RJ; Cipolle RJ
    Am J Hosp Pharm; 1987 May; 44(5):1086-9. PubMed ID: 3605118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, manufacture, and distribution of animal drugs.
    Miller CC
    J Dairy Sci; 1978 May; 61(5):665-8. PubMed ID: 670483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Requirements for PET Drug Production.
    Schwarz SW; Dick D; VanBrocklin HF; Hoffman JM
    J Nucl Med; 2014 Jul; 55(7):1132-7. PubMed ID: 24914057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data integrity-conduct of clinical investigations: university investigator perspective.
    Crooker BA; Preston RL; Boyd RD
    J Anim Sci; 1995 Feb; 73(2):622-7; discussion 627-8. PubMed ID: 7601799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA regulations for growth factors and related products.
    Chapekar MS; Gunter KC
    EXS; 1992; 61():471-8. PubMed ID: 1617242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delegations of authority and organization; new drug applications--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Jun; 47(120):26822-3. PubMed ID: 10255868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food and Drug Administration regulations and licensure.
    Barker LF
    Fed Proc; 1975 May; 34(6):1522-4. PubMed ID: 1126452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.